A gene called SOX9 helps brain tumor cells turn aggressive early on
Original title: Early SOX9 Activation Primes Hippo-YAP/TAZ Rewiring During Glioblastoma Stemness Acquisition.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in lab cells and in mice.
The short version
Lab tests show a gene named SOX9 acts early, when brain tumor cells first become dangerous.
What was studied. Researchers studied glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells and tumors grown in mice. They read the genes of single cells, mapped where the cells sat in the tumor, and turned SOX9 up and down to see what changed.
What they found. SOX9 was highest early, when normal brain cells were turning into tumor cells. It dropped once the tumor cells settled into their new state. Turning SOX9 up made cells grow, move, and invade more, and turning it down did the opposite. SOX9 was most closely tied to tumor cells in the area around blood vessels.
What this means, and what it doesn't
What it could mean: This points to a possible target for future drugs. It also suggests timing may matter, since SOX9 seems to act only during a short early window. Any treatment based on this is still far off.
What it doesn't mean: This is early lab work in cells and in mice. No one was treated in this study. It does not mean a new drug is coming soon, and it is not a cure. Nothing here changes the care you get today.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.